25% – 35%
of a hospital’s contract pharmacy opportunity lies in referral prescriptions

There are several ways to enhance, boost, and optimize 340B savings. This white paper looks at how capturing referrals can benefit a covered entity’s 340B program savings and mission.

HRSA GUIDELINES REGARDING REFERRALS

According to HRSA guidelines, a covered entity may send a patient to an outside clinic not registered with 340B and consider the patient 340B-eligible only if that patient receives care from a healthcare professional who is either employed by the covered entity or provides healthcare under contractual or other arrangements (e.g., referral for consultation) such that the responsibility for the patient’s care remains with the covered entity. If the covered entity can document that it retained responsibility for the services provided to the patient, then that individual may be eligible to receive 340B drugs from the covered entity.¹

To meet these criteria, the covered entity’s medical record must show the referral order by the eligible provider in an eligible clinic, as well as a summary of the diagnosis and care provided

SPONSORED CONTENT

Do you provide clinical care for patients living with or at risk of HIV? If so, you know how important it is to consider their needs beyond the clinic visit.

The patient journey is not linear. Social stigma, family issues, mental health challenges, financial hardship, and fear of discrimination are only a few obstacles patients may face. When individuals come to your clinic for care, it is often just the first step in a complicated journey to better health. Although accessing your services is a crucial step towards engaging in a patient’s own sexual wellness, keeping them adherent to their medications often presents a separate set of challenges.

Clinics like yours do so much to treat patients and help them stay adherent. However, an important resource in the care continuum is often underutilized: the pharmacy team.

Patients and health care providers alike sometimes assume that one pharmacy is as good as the next when it

SPONSORED CONTENT

Acentrus Specialty hosted its first Acentrus Specialty Conference on January 12-13, 2021, which brought together pharmacists, manufacturers, and suppliers to examine the challenges, opportunities, and best practices in advancing health system specialty pharmacy practice. A pharmacy paradigm shift is under way, as Integrated Delivery Networks (IDNs) are partnering to grow their specialty pharmacy operations.

“The conference highlighted the collaborative potential of our client network,” says George Zula, RPh, MBA, CSP, Acentrus Specialty Vice President. “It provided a valuable forum for specialty pharmacy leaders to network, share best practices, and focus collectively on working together to produce the data and operational insights that will drive excellence in patient care and outcomes.”

It is increasingly important for health system specialty pharmacies (HSSPs) to participate with a network administrator such as Acentrus, which allows data exchange to create metrics that demonstrate positive patient outcomes and cost-effectiveness.
—Chris Hatwig, RPh, MS, FASHP, Apexus President

Today, one in four hospitals operate specialty pharmacies, a ratio that increases to nine